探讨适合中国2型糖尿病人群的胰岛素治疗新策略  

A New Strategy of Insulin Therapy Suitable for Type 2 Diabetics in China

作　　者：梁琳琅[1] LIANG Lin-lang(Department of Endocrinology,The General Hospital of Shenyang Military,Shenyang Liaoning 110016,China)

机构地区：[1]沈阳军区总医院内分泌科,辽宁沈阳110016

出　　处：《药品评价》2018年第15期5-8,42,共5页Drug Evaluation

摘　　要：《中国2型糖尿病防治指南(2017年版)》指南治疗路径的更新,尤其是胰岛素治疗路径更加灵活及完善,充分体现了临床实践中需要以患者为中心,制定积极且调整灵活的个性化胰岛素方案。灵活的胰岛素治疗策略的制定是基于疾病的需求,我们结合中国指南,通过对中国循证证据的汇总分析,以探讨提高患者长期治疗依从性的胰岛素治疗策略。The update of treatment path in Chinese guideline for the prevention and control of type 2 diabetes(2017 edition),especially for the insulin treatment path,which is more flexible and perfect.The new guideline fully reflects the needs for patients in clinical practice,and recommends developing a proactive and flexible personalized insulin protocol.Formulating flexible personalized insulin protocol was based on the needs of disease.In combination with the Chinese guideline,through a summary analysis of evidence in China,we hope to find an insulin therapy strategy,which is suitable for the people of type 2 diabetes in China,to improve the patient's long-term treatment compliance.

关 键 词：糖尿病 2型 指南 胰岛素 治疗策略 

分 类 号：R587.1[医药卫生—内分泌]